The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma

Peer Review reports

Original Submission
27 Apr 2010	Submitted	Original manuscript
13 Jul 2010	Reviewed	Reviewer Report - David Henry
1 Sep 2010	Reviewed	Reviewer Report - Ruth Pettengell
22 Oct 2010	Author responded	Author comments - Laetitia GERLIER
Resubmission - Version 2
22 Oct 2010	Submitted	Manuscript version 2
22 Oct 2010	Author responded	Author comments - Laetitia GERLIER
Resubmission - Version 3
22 Oct 2010	Submitted	Manuscript version 3
9 Nov 2010	Author responded	Author comments - Laetitia GERLIER
Resubmission - Version 4
9 Nov 2010	Submitted	Manuscript version 4
15 Nov 2010	Author responded	Author comments - Laetitia GERLIER
Resubmission - Version 5
15 Nov 2010	Submitted	Manuscript version 5
Resubmission - Version 6
	Submitted	Manuscript version 6
22 Nov 2010	Author responded	Author comments - Laetitia GERLIER
Resubmission - Version 7
22 Nov 2010	Submitted	Manuscript version 7
Publishing
23 Nov 2010	Editorially accepted
23 Nov 2010	Article published	10.1186/1471-2407-10-642

Back to article page